Multicenter, noninterventional, post-marketing surveillance study to evaluate dosing of recombinant human follicle-stimulating hormone using the redesigned follitropin alfa pen in women undergoing ovulation induction.

Drug Healthc Patient Saf · 2015 · PMC4403741 · PMID 25926755

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a slight trendno p-value reported

However, as might be expected, there was a slight trend to suggest a reduced rate of monofollicular or bifollicular development with increasing age.

also in 2,443 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.